Unternehmen Summit Therapeutics plc London S.E.
Aktien
A115K3
GB00BN40HZ01
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11.11.20 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 01.12.19 |
Director of Finance/CFO | 46 | 01.12.19 | |
Howard West
CTO | Chief Tech/Sci/R&D Officer | - | 19.10.23 |
Allen Yang
CTO | Chief Tech/Sci/R&D Officer | - | 16.10.23 |
Will Black
CTO | Chief Tech/Sci/R&D Officer | - | - |
Dave Gancarz
PRN | Corporate Officer/Principal | - | - |
Campbell Hair
HRO | Human Resources Officer | - | 01.10.20 |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 03.11.21 |
Shelley Spray
PRN | Corporate Officer/Principal | 59 | 01.06.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 01.12.19 |
Robert Booth
BRD | Director/Board Member | 70 | 28.09.22 |
Director of Finance/CFO | 46 | 01.12.19 | |
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11.11.20 |
Kenneth Clark
BRD | Director/Board Member | 65 | 07.10.21 |
Director/Board Member | 63 | 15.11.22 | |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 03.11.21 |
Michelle Xia
BRD | Director/Board Member | 58 | 16.01.23 |
Ujwala Mahatme
BRD | Director/Board Member | 59 | 13.07.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 701 979 596 | 83 228 173 ( 11,86 %) | 0 | 11,86 % |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+10.79% | 116 Mrd. | |
+11.65% | 106 Mrd. | |
-6.20% | 23.89 Mrd. | |
-3.06% | 21.58 Mrd. | |
-8.75% | 18.96 Mrd. | |
-13.41% | 16.33 Mrd. | |
-40.50% | 16.96 Mrd. | |
+6.64% | 14.14 Mrd. | |
+31.84% | 12.02 Mrd. |